-
1
-
-
0016251063
-
Role of diabetes in congestive heart failure: The Framingham Study
-
Kannel WB, Hjortland M and Castelli WP. Role of diabetes in congestive heart failure: the Framingham Study. Am J Cardiol 1974; 34: 29-34.
-
(1974)
Am J Cardiol
, vol.34
, pp. 29-34
-
-
Kannel, W.B.1
Hjortland, M.2
Castelli, W.P.3
-
2
-
-
33644876070
-
Glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavík Study
-
DOI 10.1097/01.hjr.0000173105.91356.4d, PII 0014983120051000000008
-
Thrainsdottir IS, Aspelund T, Hardarson T, Malmberg K, Sigurdsson G, Thorgeirsson G, et al. Glucose abnormalities and heart failure predict poor prognosis in the population-based Reykjavík Study. Eur J Cardiovasc Prev Rehabil 2005; 12: 465-471. (Pubitemid 44966791)
-
(2005)
European Journal of Cardiovascular Prevention and Rehabilitation
, vol.12
, Issue.5
, pp. 465-471
-
-
Thrainsdottir, I.S.1
Aspelund, T.2
Hardarson, T.3
Malmberg, K.4
Sigurdsson, G.5
Thorgeirsson, G.6
Gudnason, V.7
Ryden, L.8
-
3
-
-
0037783946
-
The impact of diabetes-related complications on healthcare costs: Results from the UK Prospective Diabetes Study (UKPDS Study No. 65)
-
Clarke P, Gray A, Legood R, Briggs A and Holman R. The impact of diabetes-related complications on healthcare costs: results from the UK Prospective Diabetes Study (UKPDS Study No. 65). Diabet Med 2003; 20: 442-450.
-
(2003)
Diabet Med
, vol.20
, pp. 442-450
-
-
Clarke, P.1
Gray, A.2
Legood, R.3
Briggs, A.4
Holman, R.5
-
4
-
-
0041356972
-
Natural history of asymptomatic left ventricular systolic dysfunction in the community
-
DOI 10.1161/01.CIR.0000085166.44904.79
-
Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC and Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation 2003; 108(8): 977-982. (Pubitemid 37048228)
-
(2003)
Circulation
, vol.108
, Issue.8
, pp. 977-982
-
-
Wang, T.J.1
Evans, J.C.2
Benjamin, E.J.3
Levy, D.4
LeRoy, E.C.5
Vasan, R.S.6
-
5
-
-
1642502319
-
National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
National Kidney Foundation
-
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al.; National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
-
(2003)
Ann Intern Med
, vol.139
, pp. 137-147
-
-
Levey, A.S.1
Coresh, J.2
Balk, E.3
Kausz, A.T.4
Levin, A.5
Steffes, M.W.6
-
6
-
-
84870967607
-
Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: The DYDA study
-
under review
-
Cioffi G, Giorda CB, Chinali M, Di Lenarda A, Faggiano P, Lucci D, et al. Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study. Eur J Cardiovasc Prev Rehabil 2010, under review.
-
(2010)
Eur J Cardiovasc Prev Rehabil
-
-
Cioffi, G.1
Giorda, C.B.2
Chinali, M.3
Di Lenarda, A.4
Faggiano, P.5
Lucci, D.6
-
8
-
-
0035845307
-
Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: A population based study
-
DOI 10.1016/S0140-6736(01)05620-3
-
Davies M, Hobbs F, Davis R, Kenkre J, Roalfe AK, Hare R, et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet 2001; 358: 439-444. (Pubitemid 32769849)
-
(2001)
Lancet
, vol.358
, Issue.9280
, pp. 439-444
-
-
Davies, M.K.1
Hobbs, F.D.R.2
Davis, R.C.3
Kenkre, J.E.4
Roalfe, A.K.5
Hare, R.6
Wosornu, D.7
Lancashire, R.J.8
-
9
-
-
0345688845
-
Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen
-
Raymond I, Pedersen F, Steensgaard-Hansen F, Green A, Busch-Sorensen M, Tuxen C, et al. Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen. Heart 2003; 89: 1422-1429. (Pubitemid 37465240)
-
(2003)
Heart
, vol.89
, Issue.12
, pp. 1422-1429
-
-
Raymond, I.1
Pedersen, F.2
Steensgaard-Hansen, F.3
Green, A.4
Busch-Sorensen, M.5
Tuxen, C.6
Appel, J.7
Jacobsen, J.8
Atar, D.9
Hildebrandt, P.10
-
10
-
-
62649111631
-
Is the aging heart similar to the diabetic heart? Evaluation of LV function of the aging heart with tissue doppler imaging
-
Cacciapuoti F, Marfella R, Paolisso G and Cacciapuoti F. Is the aging heart similar to the diabetic heart? Evaluation of LV function of the aging heart with tissue doppler imaging. Aging Clin Exp Res 2009; 21: 22-26.
-
(2009)
Aging Clin Exp Res
, vol.21
, pp. 22-26
-
-
Cacciapuoti, F.1
Marfella, R.2
Paolisso, G.3
Cacciapuoti, F.4
-
11
-
-
66549122728
-
Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus
-
Goode KM, John J, Rigby AS, Kilpatrick ES, Atkin SL, Bragadeesh T, et al. Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus. Heart 2009; 95: 917-923.
-
(2009)
Heart
, vol.95
, pp. 917-923
-
-
Goode, K.M.1
John, J.2
Rigby, A.S.3
Kilpatrick, E.S.4
Atkin, S.L.5
Bragadeesh, T.6
-
12
-
-
0026700511
-
Effects of metabolic control on ventricular function in type 2 diabetic patients
-
Hirai J, Ueda K, Takegoshi T and Mabuchi H. Effects of metabolic control on ventricular function in type 2 diabetic patients. Intern Med 1992; 31: 725-730.
-
(1992)
Intern Med
, vol.31
, pp. 725-730
-
-
Hirai, J.1
Ueda, K.2
Takegoshi, T.3
Mabuchi, H.4
-
13
-
-
49449083742
-
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program
-
CHARM Program Investigators
-
Gerstein HC, Swedberg K, Carlsson J, McMurray JJ, Michelson EL, Olofsson B, et al.; CHARM Program Investigators. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Arch Intern Med 2008; 168: 1699-1704.
-
(2008)
Arch Intern Med
, vol.168
, pp. 1699-1704
-
-
Gerstein, H.C.1
Swedberg, K.2
Carlsson, J.3
McMurray, J.J.4
Michelson, E.L.5
Olofsson, B.6
-
14
-
-
34247606478
-
Incidence of coronary heart disease in type 2 diabetic men and women: Impact of microvascular complications, treatment, and geographic location
-
DOI 10.2337/dc06-2558
-
Avogaro A, Giorda C, Maggini M, Mannucci E, Raschetti R, Lombardo F, et al. Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care 2007; 30: 1241-1247. (Pubitemid 46684654)
-
(2007)
Diabetes Care
, vol.30
, Issue.5
, pp. 1241-1247
-
-
Avogaro, A.1
Giorda, C.2
Maggini, M.3
Mannucci, E.4
Raschetti, R.5
Lombardo, F.6
Spila-Alegiani, S.7
Turco, S.8
Velussi, M.9
Ferrannini, E.10
-
15
-
-
34247880463
-
Incidence and risk factors for stroke in type 2 diabetic patients: The DAI study
-
DAI Study Group
-
Giorda CB, Avogaro A, Maggini M, Lombardo F, Mannucci E, Turco S, et al.; DAI Study Group. Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke 2007; 38: 1154-1160.
-
(2007)
Stroke
, vol.38
, pp. 1154-1160
-
-
Giorda, C.B.1
Avogaro, A.2
Maggini, M.3
Lombardo, F.4
Mannucci, E.5
Turco, S.6
-
16
-
-
17444386290
-
Determinants of subclinical diabetic heart disease
-
DOI 10.1007/s00125-004-1632-z
-
Fang ZY, Schull-Meade R, Downey M, Prins J and Marwick TH. Determinants of subclinical diabetic heart disease. Diabetologia 2005; 48: 394-402. (Pubitemid 40543314)
-
(2005)
Diabetologia
, vol.48
, Issue.2
, pp. 394-402
-
-
Fang, Z.Y.1
Schull-Meade, R.2
Downey, M.3
Prins, J.4
Marwick, T.H.5
-
17
-
-
34247253225
-
The safety of metformin in heart failure
-
DOI 10.1345/aph.1H523
-
Roberts F and Ryan GJ. The safety of metformin in heart failure. Ann Pharmacother 2007; 41: 642-646. (Pubitemid 46625487)
-
(2007)
Annals of Pharmacotherapy
, vol.41
, Issue.4
, pp. 642-646
-
-
Roberts, F.1
Ryan, G.J.2
-
18
-
-
34548603259
-
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: Systematic review
-
Eurich DT, McAlister FA, Blackburn DF, Majumdar SR, Tsuyuki RT, Varney J, et al. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ 2007; 335: 497.
-
(2007)
BMJ
, vol.335
, pp. 497
-
-
Eurich, D.T.1
McAlister, F.A.2
Blackburn, D.F.3
Majumdar, S.R.4
Tsuyuki, R.T.5
Varney, J.6
-
19
-
-
0032860998
-
2+ transients in adult rat ventricular myocytes
-
DOI 10.2337/diabetes.48.10.2059
-
Ren J, Dominguez LJ, Sowers JR and Davidoff AJ. Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes. Diabetes 1999; 48: 2059-2065. (Pubitemid 29458372)
-
(1999)
Diabetes
, vol.48
, Issue.10
, pp. 2059-2065
-
-
Ren, J.1
Dominguez, L.J.2
Sowers, J.R.3
Davidoff, A.J.4
-
20
-
-
17844393082
-
Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding
-
Mamdani M, Sykora K, Li P, Notmand TS-L, Steiner LD, Austin CP, et al. Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005; 330: 960-962.
-
(2005)
BMJ
, vol.330
, pp. 960-962
-
-
Mamdani, M.1
Sykora, K.2
Li, P.3
Notmand, T.S.-L.4
Steiner, L.D.5
Austin, C.P.6
-
21
-
-
53749096863
-
10-year follow-up of intensive glucose control in type 2 diabetes
-
Holman RR, Paul SK, Bethel MA, Matthews DR and Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589.
-
(2008)
N Engl J Med
, vol.359
, pp. 1577-1589
-
-
Holman, R.R.1
Paul, S.K.2
Bethel, M.A.3
Matthews, D.R.4
Neil, H.A.5
-
22
-
-
0042835370
-
Diuretic versus alpha-blocker as first-step antihypertensive therapy: Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
-
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension 2003; 42: 239-246.
-
(2003)
Hypertension
, vol.42
, pp. 239-246
-
-
-
23
-
-
0037453063
-
Glitazones and heart failure: Critical appraisal for the clinician
-
DOI 10.1161/01.CIR.0000054675.30348.9A
-
Wang CH, Weisel RD, Liu PP, Fedak PW and Verma S. Glitazones and heart failure: critical appraisal for the clinician. Circulation 2003; 107: 1350-1354. (Pubitemid 36350730)
-
(2003)
Circulation
, vol.107
, Issue.10
, pp. 1350-1354
-
-
Wang, C.-H.1
Weisel, R.D.2
Liu, P.P.3
Fedak, P.W.M.4
Verma, S.5
-
24
-
-
0035797865
-
Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes
-
Yamamoto K, Ohki R, Lee RT, Ikeda U and Shimada K. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation 2001; 104: 1670-1675. (Pubitemid 32947532)
-
(2001)
Circulation
, vol.104
, Issue.14
, pp. 1670-1675
-
-
Yamamoto, K.1
Ohki, R.2
Lee, R.T.3
Ikeda, U.4
Shimada, K.5
-
25
-
-
42649097971
-
Relation among left ventricular mass, insulin resistance, and hemodynamic parameters in type 2 diabetes
-
DOI 10.1291/hypres.31.425
-
Ozasa N, Furukawa Y, Tadamura E, Kita T and Kimura T. Relation among left ventricular mass, insulin resistance, and hemodynamic parameters in type 2 diabetes. Hypertens Res 2008; 31: 425-432. (Pubitemid 351597495)
-
(2008)
Hypertension Research
, vol.31
, Issue.3
, pp. 425-432
-
-
Ozasa, N.1
Furukawa, Y.2
Morimoto, T.3
Tadamura, E.4
Kita, T.5
Kimura, T.6
-
26
-
-
43549099569
-
Biomarkers in heart failure
-
Braunwald E. Biomarkers in heart failure. N Engl J Med 2008; 358: 2148-2159.
-
(2008)
N Engl J Med
, vol.358
, pp. 2148-2159
-
-
Braunwald, E.1
|